SHR-1210 Plus Apatinib in Patients With Hepatocellular Carcinoma After Surgery
Clinical trial NCT03722875 · UNKNOWN
Trial details
- NCT number
- NCT03722875
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-01
- Primary completion
- 2019-03-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.